Curis
CRIS
#10187
Rank
S$16.69 M
Marketcap
S$1.22
Share price
-5.93%
Change (1 day)
-69.11%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -S$42.89 Million

According to Curis's latest financial reports the company's current earnings are S$11.65 Million. In 2024 the company made an earning of -S$54.71 Million, an increase over its 2023 earnings that were of -S$58.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$42.89 Million-21.61%
2024 -S$54.71 Million-5.77%
2023 -S$58.06 Million-13.1%
2022 -S$66.82 Million27.52%
2021 -S$52.4 Million65.09%
2020 -S$31.74 Million-9.1%
2019 -S$34.92 Million-4.73%
2018 -S$36.65 Million-41.95%
2017 -S$63.13 Million-14.37%
2016 -S$73.72 Million3.55%
2015 -S$71.19 Million271.52%
2014 -S$19.17 Million76.64%
2013 -S$10.85 Million
2011 -S$9.22 Million27.76%
2010 -S$7.22 Million-43.87%
2009 -S$12.85 Million-23.44%
2008 -S$16.79 Million56.66%
2007 -S$10.72 Million-16.71%
2006 -S$12.87 Million-36.92%
2005 -S$20.39 Million156.25%
2004 -S$7.96 Million-37.24%
2003 -S$12.68 Million-93.34%
2002 -S$0.2 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.15 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.27 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$79.15 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.11 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.33 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$31.68 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA